Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;5(3):134-7.
doi: 10.4161/org.5.3.9585.

Preservation of stem cells

Jacob Hanna  1 , Allison Hubel
Affiliations

Preservation of stem cells

Jacob Hanna et al. Organogenesis. 2009 Jul.

Abstract

Adult stem cells (hematopoietic and mesenchymal) have demonstrated tremendous human therapeutic potential. Currently, human embryonic stem cells are used principally for understanding development and disease progression but also hold tremendous therapeutic potential. The ability to preserve stem cells is critical for their use in clinical and research applications. Preservation of cells permits the transportation of cells between sites, as well as completion of safety and quality control testing. Preservation also permits the development of a 'manufacturing paradigm' for cell therapies, thereby maximizing the number of products that can be produced at a given facility. in this article, we will review modes of preservation and the current status of preservation of hematopoietic, mesenchymal and human embryonic stem cells. Current and emerging issues in the area of stem cell preservation will also be described.

Keywords: cell therapy; cryopreservation; preservation; stabilization; stem cells.

PubMed Disclaimer

References

    1. Baron F, Storb R, Little MT. Hematopoietic cell transplantation: five decades of progress. Arch Med Res. 2003;34:528–544. - PubMed
    1. Haider H, Ashraf M. Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol. 2005;288:2557–2567. - PubMed
    1. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, et al. Results of minimally toxic non-myeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519–528. - PubMed
    1. Ikehara S. Bone marrow transplantation: a new strategy for intractable diseases. Drugs Today (Barc) 2002;38:103–111. - PubMed
    1. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259–264. - PubMed

LinkOut - more resources